Objective: Fibroblast growth factor 21 (FGF21), a key regulator of the metabolic response to fasting, is highly induced by endoplasmic reticulum (ER) stress. The X-box binding protein 1 (Xbp1) is one of several ER stress proteins that has been shown to directly activate the FGF21 promoter. We aimed to determine whether hepatic Xbp1 is required for induction of hepatic FGF21 in vivo. Methods: Mice bearing a hepatocyte-specific deletion of Xbp1 (Xbp1 LKO ) were subjected to fasting, pharmacologic ER stress, or a ketogenic diet, all potent stimuli of Fgf21 expression. Results: Hepatocyte-specific Xbp1 knockout mice demonstrated normal induction of FGF21 in response to fasting or pharmacologic ER stress and enhanced induction of FGF21 in response to a ketogenic diet. Consistent with preserved induction of FGF21, Xbp1 LKO mice exhibited normal induction of FGF21 target genes and normal ketogenesis in response to fasting or a ketogenic diet. Conclusion: Hepatic Xbp1 is not required for induction of FGF21 under physiologic or pathophysiologic conditions in vivo.
INTRODUCTION
Fasting induces well-characterized changes in hepatic lipid and glucose metabolism that are critical to maintaining energy balance within an organism. Fibroblast growth factor 21 (FGF21) has emerged as a key regulator of the metabolic response to fasting [1e3] . In the fasted state, increased serum free fatty acids released from lipolysis of adipose tissue lead to activation of peroxisome proliferator-activated receptor a (PPARa), a major inducer of FGF21 [1, 2, 4] . FGF21, in turn, promotes fatty acid b-oxidation, gluconeogenesis, and ketogenesis, key adaptive responses to starvation [5, 6] . In addition to its physiologic role in mediating the metabolic response to fasting, FGF21 is increasingly recognized to have broader metabolic actions. Moreover, induction of FGF21 is a well-established feature of both rodent and human metabolic diseases such as obesity, type II diabetes, and nonalcoholic fatty liver disease (NAFLD) [7e17] . Furthermore, systemically administered FGF21 has been shown to lower blood glucose and triglycerides, and improve obesity, hepatic steatosis, and insulin resistance [18e21] . Interestingly, in humans, FGF21 is not dramatically induced by short-term fasting but is robustly induced by fructose or sucrose ingestion [13,22e24] . These observations have raised speculation that the primary function of FGF21 in humans may be to counteract metabolic disease rather than mediate the adaptive response to starvation. Given the massive public health burden that obesity and its sequelae impose, the regulation of FGF21 has been an area of intense investigation in recent years. In addition to fasting and metabolic disturbance, endoplasmic reticulum (ER) stress is now a well-established inducer of hepatic FGF21 expression [25, 26] . ER stress and the ensuing unfolded protein response (UPR), have been increasingly implicated in the pathogenesis of metabolic diseases such as obesity, type II diabetes, and NAFLD. As such, it has been speculated that induction of FGF21 by ER stress may serve to counteract the negative metabolic consequences of unresolved ER stress [25, 27, 28] . Although it is widely accepted that ER stress, among other cellular stressors, induces hepatic FGF21 expression, the mechanism remains controversial. ER stress response elements have been identified in the Fgf21 promoter that are capable of binding several ER stress-induced transcription factors [25e27]. The PERK-eIF2a-ATF4 branch of the UPR in particular has clearly been shown to mediate ER stress-induced FGF21 expression in vitro and in vivo [25, 28] ; however, the physiologic role of other ER stress-induced transcription factors in the regulation of FGF21 is less well understood.
The IRE1a-XBP1 branch of the UPR has been strongly implicated in regulating hepatic lipid and glucose metabolism, making this particular branch of the UPR an intriguing candidate for mediating the effect of ER stress on FGF21 expression [29e31]. XBP1 has been shown to bind to the promoter of FGF21 in vitro, and there has been recent interest in and controversy over the role of XBP1 in the regulation of FGF21 [25e 27]. In vitro experiments have shown that overexpression of XBP1s in primary hepatocytes induces FGF21 expression whereas knockdown of XBP1 blunts FGF21 induction [27] . Furthermore, it has previously been shown that mice bearing a liver-specific deletion of Ire1a, the primary activator of Xbp1, show impaired activation of Fgf21 when challenged with pharmacologic ER stress [27] . Despite this compelling data, the role of hepatic Xbp1 in the regulation of hepatic Fgf21 under physiologic or pathophysiologic conditions remains unclear. To directly determine whether hepatic Xbp1 is required for induction of hepatic Fgf21 in vivo, we subjected mice bearing a hepatocyte-specific deletion of Xbp1 to fasting, a ketogenic diet, or pharmacologic ER stress, all potent stimuli of Fgf21 expression.
EXPERIMENTAL PROCEDURES

Animals and treatments C57BL/6 -Xbp1
fl/fl mice with loxP sites flanking exon 2 of the Xbp1 gene were kindly provided by Dr. Laurie H. Glimcher. The generation of the Xbp1 fl/fl strain has been previously reported [29] . Xbp1 fl/fl mice were bred with C57BL/6 -Albumin-Cre mice (Jackson Laboratory, ME) that express Cre-recombinase in albumin-producing hepatocytes as previously described [32] . were treated with a single intraperitoneal injection of tunicamycin (0.5 mg/kg) or vehicle (20% DMSO/PBS) and were sacrificed 6 h postinjection. All mice underwent 14/10-hour light/dark cycling before and during the treatment protocol and were given free access to water during dietary manipulation. Mice were sacrificed by CO 2 inhalation followed by cardiac puncture. The cardiac blood was immediately centrifuged to collect the plasma. The livers were rapidly excised, flushed with ice-cold saline, and sectioned. An aliquot of liver was fixed in formalin and the remaining liver was snap-frozen in liquid nitrogen. All animal protocols were approved by the Northwestern University Institutional Animal Care and Use Committee (IACUC).
Liver and plasma chemistries
Plasma FGF21 levels were measured using an FGF21 ELISA assay kit (RND Systems, Minneapolis, MN). Plasma b-hydroxybutyrate levels were measured using a biochemical assay (Stanbio Laboratory, Boerne, TX). Glucose was measured on whole blood obtained by tail bleed using a One Touch Ultra glucometer (Lifescan, Milpitas, CA). Plasma insulin was measured using an Insulin ELISA assay kit (Thermo Scientific, Frederick, MD). The homeostatic model assessment of insulin resistance (HOMA-IR) was calculated as (fasting glucose (in mg/dL) X fasting insulin (mU/L))/405. Plasma FGF21, b-hydroxybutyrate, and insulin were measured on plasma collected from cardiac blood at the termination of the experiment. Liver samples were homogenized in Dulbecco's phosphate buffered saline for hepatic lipid analysis (100 mg liver tissue/1 mL). Triglyceride levels were measured in liver homogenate using an Infinity spectrophotometric assay per the manufacturer's protocol (Thermo Electron Corporation, Melbourne, Australia).
Cell culture experiments
Human hepatoma Huh7 cells transfected with short hairpin RNA (shRNA) targeting XBP1 ( Huh7 shXBP1 ) or control shRNA (Huh7 shCON ) were generated and characterized as previously described [33] (kindly provided by Dr. Richard Green, Northwestern University, Chicago, IL). Huh7 shCON and Huh7 shXBP1 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, Lglutamine, and penicillin-streptomycin at 37 C with 5% CO2. To induce ER stress, cells were grown to 80% confluence in 6-well plates and treated with tunicamycin (5 mg/mL) or vehicle (DMSO/saline) in serum-free media for 6 h. RNA isolation was performed using TRIzol Reagent (Ambion Life Technologies, Carlsbad, CA) per protocol.
Analysis of gene and protein expression
Total RNA from frozen liver or cultured cells was isolated using TRIzol reagent, and real-time quantitative PCR was performed as previously described [34, 35] . Total protein was isolated from frozen liver samples, and western blotting was performed as previously described [34, 35] . Protein detection was performed using polyclonal rabbit antibodies to IRE1a, CHOP, total and phosphorylated eIF2a, and GAPDH (Cell Signaling Technology, Danvers, MA). Bound antibody was detected using goat anti-rabbit polyclonal HRP antibody (Cell Signaling Technology) and developed using ECL Western Blotting Substrate (Cell Signaling Technology). Representative western blots of pooled samples are shown.
Statistical analysis
Data are presented as mean AE standard deviation (SD). Comparisons between groups were performed using Student's t-test analysis.
RESULTS
Hepatic Xbp1 is not required for induction of hepatic Fgf21 in response to fasting
We first examined the effect of hepatic Xbp1-deletion on induction of Fgf21 in response to fasting, a potent stimulus of hepatic Fgf21 expression. As expected, fasting markedly increased the hepatic expression of Fgf21 in Xbp1 fl/fl control mice ( Figure 1A ). Paralleling the induction of hepatic Fgf21 expression, the plasma concentration of FGF21 was also markedly increased by fasting ( Figure 1B ). Surprisingly, Xbp1 LKO mice showed an equivalent increase in hepatic Fgf21 expression and plasma FGF21 concentration relative to Xbp1 fl/fl mice in response to fasting ( Figure 1A ,B however, whether the metabolic effects of FGF21 are mediated by Pgc1a is controversial [5, 6, 36] . Paralleling the induction of Fgf21 among Xbp1 LKO mice, the hepatic expression of Pgc1a was appropriately induced by fasting in Xbp1 LKO mice ( Figure 1C ). FGF21 has also been shown to regulate other key genes controlling fatty acid boxidation including carnitine palmitoyl acyl-CoA transferase 1 (Cpt1a) and acyl-CoA-oxidase (Aco) [1, 6] . Xbp1 LKO mice showed equivalent induction of hepatic Cpt1a and Aco expression relative to Xbp1 fl/fl mice in response to fasting ( Figure 1D ,E). Consistent with normal induction of fatty acid oxidation genes, Xbp1 LKO and Xbp1 fl/fl control mice showed an equivalent increase in plasma b-hydroxybutyrate in response to fasting ( Figure 1F ). These data suggest that hepatic Xbp1
is not a major regulator of fatty acid b-oxidation in response to fasting.
Complementary to its role in regulating fasting-induced fatty acid oxidation, FGF21 has also been shown to be a critical regulator of glucose metabolism [19,37e41] . Consistent with the known function of hepatic Xbp1 in regulating glucose metabolism [42e45], we found that Xbp1 LKO mice demonstrated increased fasting blood glucose, a trend toward increased fasting plasma insulin, and an increased HOMA-IR relative to control mice ( Figure 1G,H,I ). Given our finding of normal FGF21 production ( Figure 1A ,B) in the setting of impaired glucose metabolism, we conclude that hepatic Xbp1 regulates glucose metabolism independently of FGF21. Figure 2C,D) . As expected, Huh7 shXBP1 knockdown cells showed 80% suppression of XBP1 mRNA at baseline and no induction of XBP1 splicing in response to ER stress. Despite the failure to induce XBP1 splicing, Huh7 shXBP1 cells showed equal induction of FGF21 expression compared to control cells in response to ER stress. These data indicate that XBP1 does not mediate ER stress-induced FGF21 activation.
Hepatic
3.3. Deletion of hepatic Xbp1 enhances ketogenic diet-induced hepatic Fgf21 expression Feeding mice a high-fat, low-carbohydrate, ketogenic diet (KD) increases circulating FGF21 levels and induces fatty acid b-oxidation pathways [1, 7] . We next examined the effect of a KD on hepatic Fgf21 expression in Xbp1 LKO and Xbp1 fl/fl mice. As expected, the KD increased hepatic expression of Fgf21 and increased plasma levels of FGF21 among Xbp1 fl/fl control mice ( Figure 3A ,B). Interestingly,
Xbp1
LKO mice fed the KD showed enhanced hepatic expression and plasma level of FGF21 relative to KD-fed Xbp1 fl/fl mice. Given this unexpected finding and the potential influence of age and sex on FGF21 levels, we repeated the experiment in older, male mice. Paralleling our findings in female mice, we found that male Xbp1 LKO mice demonstrated increased hepatic expression of Fgf21 and higher plasma levels of FGF21 compared to male Xbp1 fl/fl mice when fed a KD ( Figure 3A,B) . Similar to our observations in the fasted state, Xbp1 (Figure 3CeE ). Hepatic Fgf21 is transcriptionally activated by several UPR signaling proteins other than Xbp1, most notably, ATF4 and CHOP [25, 26] . We considered whether the enhanced hepatic Fgf21 expression observed in Xbp1 LKO mice fed a KD may be due to compensatory hyperactivation of non-Xbp1-dependent elements of the UPR. Feeding a KD was and Chop, as well as increased protein levels of phosphorylated IRE1a, phosphorylated eIF2a, and CHOP ( Figure 4 ). As we and others have previously shown [29, 32] , Xbp1 LKO mice showed a near-absence of hepatic spliced Xbp1 mRNA and compensatory hyperactivation of IRE1a at baseline ( Figure 4A,B) . In response to a KD, Xbp1 LKO mice showed enhanced activation of hepatic IRE1 relative to Xbp1 fl/fl mice.
LKO showed a similar degree of activation of the eIF2a-ATF4 signaling cascade as evidenced by equal hepatic levels of phosphorylated eIF2a protein and Atf4 mRNA ( Figure 4A,C) . On the contrary, Xbp1 LKO mice showed markedly enhanced induction of hepatic CHOP at both the mRNA and protein level relative to Xbp1 fl/fl mice when fed a KD ( Figure 4A,D) . Consistent with enhanced induction of CHOP, KD-fed Xbp1 LKO mice showed enhanced hepatic expression of death receptor 5 (Dr5), a pro-apoptotic transcriptional target of CHOP ( Figure 4E) . It has been shown that mice lacking hepatic Xbp1 are protected from lipogenic diet-induced hepatic steatosis associated with suppressed expression of lipogenesis genes [29, 33] . Xbp1 fl/fl mice fed a KD for 2 weeks showed a four-fold increase in hepatic triglyceride content associated with scant hepatic steatosis on H&E staining of liver sections ( Figure 4F,G) . There was no overt histologic evidence of liver injury or fibrosis at this early time point. Consistent with the known effect of hepatic Xbp1-deletion on hepatic lipid accumulation, we found that Xbp1 LKO mice fed a KD showed reduced hepatic steatosis ( Figure 4F ), modestly attenuated hepatic triglyceride accumulation ( Figure 4G) , and enhanced suppression of hepatic lipogenesis genes ( Figure 4H ) relative to Xbp1 fl/fl mice.
DISCUSSION
FGF21 is a key regulator of the metabolic response to fasting and has been shown to be highly induced by ER stress [25, 26] . UPR response elements have been identified within the Fgf21 promoter, and several UPR signaling elements have been implicated in the regulation of Fgf21 including ATF4, CHOP, and XBP1 [25e27]. While the PERK-eIF2a-ATF4 branch of the UPR has been strongly implicated in the regulation of ER stress-induced FGF21 expression, the physiologic role of XBP1 in FGF21 regulation is controversial [25, 27, 28, 46] . We find that mice lacking hepatic Xbp1 show normal induction of hepatic Fgf21 in response to fasting, pharmacologic ER stress, or a ketogenic diet. Furthermore, we find that a human cell line bearing a stable knockdown of XBP1 also demonstrates normal induction of FGF21 in response to ER stress. Although Xbp1 is capable of binding to UPR response elements within the Fgf21 promoter, our data demonstrate that Xbp1 is not required for induction of Fgf21 under physiologic or pathophysiologic conditions. It has been shown previously that mice bearing a liver-specific deletion of Ire1a show impaired activation of hepatic Fgf21 when challenged with pharmacologic ER stress [27] . It has been speculated that the effect of Ire1a-deletion on hepatic Fgf21 is a consequence of impaired Xbp1 splicing in this model. Challenging hepatocyte-specific Xbp1 knockout mice with stimuli that induce hepatic Fgf21 is the most direct and definitive way to determine whether Xbp1 is required for Fgf21 activation in vivo. Our observation that mice lacking hepatic Xbp1 demonstrate normal induction of Fgf21 in response to fasting, ER stress, and a ketogenic diet clearly demonstrates that hepatic Xbp1 is not necessary for [28] . Furthermore, they demonstrate that Xbp1-/-MEF cells show normal induction of FGF21 in response to pharmacologic ER stress whereas cells lacking PERK, eIF2a, or ATF4 demonstrate impaired FGF21 induction [28] . Similarly, others have concluded that the PERK-eIF2a-ATF4 branch, not the IRE1a-XBP1 branch, of the UPR is the major mediator of FGF21 induction under conditions of cellular stress in vitro [25] . Our data support the conclusion that XBP1 is not a major mediator of ER stress-induced FGF21 transcription in vitro.
Unexpectedly we find that not only is hepatic Xbp1 not required for Fgf21 induction but deletion of hepatic Xbp1 actually may enhance ketogenic diet-induced FGF21 elevation. In exploring a potential mechanism for this finding, we considered whether a heightened stress response in the livers of Xbp1 LKO mice may be the cause of enhanced hepatic Fgf21 expression. Feeding mice a ketogenic diet induced ER stress, and deletion of hepatic Xbp1 enhanced ketogenic diet-induced UPR activation. In particular, we found that ketogenic diet-fed Xbp1 LKO mice showed markedly enhanced induction of hepatic CHOP, a known regulator of Fgf21 [26] . We speculate that the enhanced hepatic stress response observed among Xbp1 LKO mice fed a ketogenic diet underlies the enhanced Fgf21 induction. Of note, the degree of FGF21 elevation we observed among the ketogenic diet-fed mice was less than what has been reported under other experimental conditions. This may be due in part to differing composition of the ketogenic diet; for example, ketogenic diets with lower protein content (e.g. Bioserv F3666) have been shown to induce FGF21 to a greater degree [47] . Furthermore, FGF21 is subject to circadian regulation and varying light/dark cycles among animal facilities as well as the time of blood collection could influence the degree of FGF21 elevation observed [48, 49] . Consistent with the known effect of hepatic Xbp1 in regulating de novo hepatic lipogenesis in response to lipogenic diets, we find that mice lacking hepatic Xbp1 have a modestly reduced hepatic triglyceride content and suppression of lipogenesis genes in response to a highfat, ketogenic diet [29, 33] . In addition to suppression of de novo lipogenesis, enhanced induction of FGF21 could also contribute to the observed reduction in hepatic lipid content among ketogenic diet-fed Xbp1 LKO mice. Moreover, induction of FGF21 has become a wellrecognized feature of NAFLD in both humans and mice and is thought to be a compensatory response aimed at reducing hepatic lipid accumulation [10, 11, 13, 16, 17] . The factors that drive FGF21 expression in a steatotic liver are not fully understood, but ER stress may be a contributing factor. Furthermore, given the role of ER stress in promoting NAFLD, it is an intriguing hypothesis that induction of FGF21 by ER stress may be an adaptive response to counteract hepatic lipid accumulation. Of note, the degree of hepatic steatosis induced by the high-fat ketogenic diet was modest relative to other commonly administered lipogenic diets, likely due to the dietary composition and short-duration of feeding. Additional studies with prolonged exposure to lipogenic diets are warranted to fully characterize the interplay between ER stress, FGF21, and NAFLD.
FGF21 has emerged as a major mediator of metabolic diseases and a highly promising target for therapeutic intervention in obesity, diabetes, and fatty liver disease. Understanding the interaction between ER stress and FGF21 may have implications for the development of metabolic disease. Moreover, discerning the relevant signals that drive FGF21 expression in vivo may uncover novel targets for obesity, diabetes and NAFLD. Herein, we provide definitive evidence that hepatic Xbp1 is not required for induction of hepatic Fgf21 under physiologic and pathophysiologic conditions in vivo.
